| Organism name | Catharanthus roseus (L.) G.DON | 
|---|---|
| Genus | Catharanthus | 
| Family | Apocynaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Catharanthus roseus | 
|---|---|
| Linked NCBI taxonomy ID | 4058 | 
| Linked level | species | 
| Family in NCBI taxonomy | Apocynaceae | 
|---|---|
| ID | 4056 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00001781   | Vinblastine | CHEMBL22969 CHEMBL159 CHEMBL150387 CHEMBL1315323 CHEMBL1437021 CHEMBL1518759 CHEMBL1625660 CHEMBL2311781 | D014747 | 136 / 73 / 75 | 208 / 97 | No. 2360 | No. 4 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001781 | 1 / 0 | 
| P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001781 | 0 / 0 | 
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00001781 | 0 / 0 | 
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001781 | 7 / 37 | 
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00001781 | 1 / 0 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001781 | 0 / 0 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00001781 | 1 / 1 | 
| O95342 | Bile salt export pump | drug | C00001781 | 2 / 1 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001781 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001781 | 0 / 3 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001781 | 2 / 2 | 
| P08246 | Neutrophil elastase | S1A | C00001781 | 2 / 1 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001781 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001781 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001781 | 0 / 0 | 
| P29466 | Caspase-1 | C14 | C00001781 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00001781 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001781 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00001781 | 2 / 2 | 
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001781 | 0 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001781 | 3 / 2 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00001781 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001781 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00001781 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00001781 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001781 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001781 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 | 
| P04183 | Thymidine kinase, cytosolic | Enzyme | C00001781 | 0 / 1 | 
| P08183 | Multidrug resistance protein 1 | drug | C00001781 | 1 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001781 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001781 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001781 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001781 | 0 / 1 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001781 | 1 / 8 | 
| P11473 | Vitamin D3 receptor | NR1I1 | C00001781 | 2 / 3 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001781 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001781 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001781 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001781 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001781 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001781 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001781 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001781 | 1 / 1 | 
| P07437 | Tubulin beta chain | Structural | C00001781 | 0 / 0 | 
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001781 | 0 / 0 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001781 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001781 | 1 / 0 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001781 | 0 / 0 | 
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001781 | 0 / 0 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001781 | 2 / 0 | 
| O75496 | Geminin | Unclassified protein | C00001781 | 0 / 0 | 
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00001781 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001781 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001781 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001781 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001781 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001781 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00001781 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001781 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001781 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001781 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001781 | 1 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001781 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00001781 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001781 | 1 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00001781 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001781 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001781 | 0 / 0 | 
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00001781 | 1 / 0 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001781 | 0 / 0 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00001781 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001781 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001781 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001781 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001781 | 2 / 0 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001781 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001781 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00001781 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001781 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001781 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001781 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001781 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001781 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001781 | 2 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001781 | 0 / 0 | 
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001781 | 1 / 1 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001781 | 0 / 0 | 
| P21439 | Multidrug resistance protein 3 | Enzyme | C00001781 | 3 / 2 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001781 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00001781 | 1 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001781 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00001781 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001781 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001781 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001781 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001781 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00001781 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001781 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001781 | 0 / 0 | 
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001781 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001781 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001781 | 0 / 1 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001781 | 0 / 0 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001781 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001781 | 4 / 3 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001781 | 0 / 0 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001781 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001781 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001781 | 1 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00001781 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001781 | 0 / 0 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001781 | 0 / 0 | 
| P40225 | Thrombopoietin | Unclassified protein | C00001781 | 1 / 1 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001781 | 0 / 0 | 
| O00255 | Menin | Unclassified protein | C00001781 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001781 | 1 / 2 | 
| Q13748 | Tubulin alpha-3C/D chain | Structural | C00001781 | 0 / 0 | 
| P68366 | Tubulin alpha-4A chain | Structural | C00001781 | 0 / 0 | 
| Q9H4B7 | Tubulin beta-1 chain | Structural | C00001781 | 1 / 0 | 
| P04350 | Tubulin beta-4A chain | Structural | C00001781 | 2 / 0 | 
| Q3ZCM7 | Tubulin beta-8 chain | Structural | C00001781 | 0 / 0 | 
| Q71U36 | Tubulin alpha-1A chain | Structural | C00001781 | 1 / 1 | 
| P68371 | Tubulin beta-4B chain | Structural | C00001781 | 0 / 0 | 
| Q13509 | Tubulin beta-3 chain | Structural | C00001781 | 2 / 1 | 
| P68363 | Tubulin alpha-1B chain | Unclassified protein | C00001781 | 0 / 0 | 
| Q13885 | Tubulin beta-2A chain | Structural | C00001781 | 0 / 0 | 
| Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | C00001781 | 0 / 0 | 
| Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | C00001781 | 0 / 0 | 
| Q9BUF5 | Tubulin beta-6 chain | Structural | C00001781 | 0 / 0 | 
| Q9BVA1 | Tubulin beta-2B chain | Structural | C00001781 | 1 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | C00001781 | 
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | C00001781 | 
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | C00001781 | 
| 3983 | ABLIM1, ABLIM, LIMAB1, LIMATIN, abLIM-1 | actin binding LIM protein 1 | C00001781 | 
| 39 | ACAT2 | acetyl-CoA acetyltransferase 2 (EC:2.3.1.9) | C00001781 | 
| 55856 | ACOT13, PNAS-27, THEM2 | acyl-CoA thioesterase 13 | C00001781 | 
| 52 | ACP1, HAAP | acid phosphatase 1, soluble (EC:3.1.3.2 3.1.3.48) | C00001781 | 
| 120 | ADD3, ADDL | adducin 3 (gamma) | C00001781 | 
| 316 | AOX1, AO, AOH1 | aldehyde oxidase 1 (EC:1.2.3.1) | C00001781 | 
| 27350 | APOBEC3C, A3C, APOBEC1L, ARDC2, ARDC4, ARP5, PBI, bK150C2.3 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C | C00001781 | 
| 521 | ATP5I, ATP5K | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E (EC:3.6.1.14) | C00001781 | 
| 9551 | ATP5J2, ATP5JL | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 (EC:3.6.1.14) | C00001781 | 
| 9212 | AURKB, AIK2, AIM-1, AIM1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5, aurkb-sv1, aurkb-sv2 | aurora kinase B (EC:2.7.11.1) | C00001781 | 
| 558 | AXL, JTK11, UFO | AXL receptor tyrosine kinase (EC:2.7.10.1) | C00001781 | 
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 | C00001781 | 
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 | C00001781 | 
| 79444 | BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50 | baculoviral IAP repeat containing 7 | C00001781 | 
| 699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) | C00001781 | 
| 56951 | C5orf15, KCT2 | chromosome 5 open reading frame 15 | C00001781 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00001781 | 
| 847 | CAT | catalase (EC:1.11.1.6) | C00001781 | 
| 891 | CCNB1, CCNB | cyclin B1 | C00001781 | 
| 9133 | CCNB2, HsT17299 | cyclin B2 | C00001781 | 
| 959 | CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L | CD40 ligand | C00001781 | 
| 34411 | C00001781 | ||
| 55143 | CDCA8, BOR, BOREALIN, DasraB, MESRGP | cell division cycle associated 8 | C00001781 | 
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) | C00001781 | 
| 1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | C00001781 | 
| 1058 | CENPA, CENP-A, CenH3 | centromere protein A | C00001781 | 
| 26586 | CKAP2, LB1, TMAP, se20-10 | cytoskeleton associated protein 2 | C00001781 | 
| 10063 | COX17 | COX17 cytochrome c oxidase copper chaperone | C00001781 | 
| 9377 | COX5A, COX, COX-VA, VA | cytochrome c oxidase subunit Va (EC:1.9.3.1) | C00001781 | 
| 1340 | COX6B1, COX6B, COXG, COXVIb1 | cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) (EC:1.9.3.1) | C00001781 | 
| 8804 | CREG1, CREG | cellular repressor of E1A-stimulated genes 1 | C00001781 | 
| 9419 | CRIPT | cysteine-rich PDZ-binding protein | C00001781 | 
| 1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor | C00001781 | 
| 6374 | CXCL5, ENA-78, SCYB5 | chemokine (C-X-C motif) ligand 5 | C00001781 | 
| 100528464 | C00001781 | ||
| 28960 | DCPS, DCS1, HINT-5, HINT5, HSL1 | decapping enzyme, scavenger (EC:3.6.1.59) | C00001781 | 
| 9416 | DDX23, PRPF28, SNRNP100, U5-100K, U5-100KD, prp28 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 (EC:3.6.4.13) | C00001781 | 
| 51071 | DERA, DEOC | deoxyribose-phosphate aldolase (putative) (EC:4.1.2.4) | C00001781 | 
| 1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) | C00001781 | 
| 22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 | C00001781 | 
| 27122 | DKK3, REIC, RIG | dickkopf WNT signaling pathway inhibitor 3 | C00001781 | 
| 29980 | DONSON, B17, C21orf60 | downstream neighbor of SON | C00001781 | 
| 1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 | C00001781 | 
| 84455 | EFCAB7, RP4-534K7.1 | EF-hand calcium binding domain 7 | C00001781 | 
| 2013 | EMP2, XMP | epithelial membrane protein 2 | C00001781 | 
| 4072 | EPCAM, DIAR5, EGP-2, EGP314, EGP40, ESA, HNPCC8, KS1/4, KSA, M4S1, MIC18, MK-1, TACSTD1, TROP1 | epithelial cell adhesion molecule | C00001781 | 
| 2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) | C00001781 | 
| 2069 | EREG, ER | epiregulin | C00001781 | 
| 2109 | ETFB, MADD | electron-transfer-flavoprotein, beta polypeptide | C00001781 | 
| 5393 | EXOSC9, PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6 | exosome component 9 (EC:3.1.13.-) | C00001781 | 
| 10447 | FAM3C, ILEI | family with sequence similarity 3, member C | C00001781 | 
| 388650 | FAM69A | family with sequence similarity 69, member A | C00001781 | 
| 55120 | FANCL, FAAP43, PHF9, POG | Fanconi anemia, complementation group L | C00001781 | 
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) | C00001781 | 
| 2237 | FEN1, FEN-1, MF1, RAD2 | flap structure-specific endonuclease 1 | C00001781 | 
| 2280 | FKBP1A, FKBP-12, FKBP-1A, FKBP1, FKBP12, PKC12, PKCI2, PPIASE | FK506 binding protein 1A, 12kDa (EC:5.2.1.8) | C00001781 | 
| 2313 | FLI1, EWSR2, SIC-1 | Fli-1 proto-oncogene, ETS transcription factor | C00001781 | 
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 | C00001781 | 
| 8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 | C00001781 | 
| 50486 | G0S2, RP1-28O10.2 | G0/G1switch 2 | C00001781 | 
| 79017 | GGCT, C7orf24, CRF21, GCTG, GGC | gamma-glutamylcyclotransferase (EC:2.3.2.4) | C00001781 | 
| 2677 | GGCX, VKCFD1 | gamma-glutamyl carboxylase (EC:4.1.1.90) | C00001781 | 
| 51053 | GMNN, Gem | geminin, DNA replication inhibitor | C00001781 | 
| 79158 | GNPTAB, GNPTA, ICD | N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (EC:2.7.8.17) | C00001781 | 
| 11245 | GPR176, HB-954 | G protein-coupled receptor 176 | C00001781 | 
| 29899 | GPSM2, CMCS, DFNB82, LGN, PINS | G-protein signaling modulator 2 | C00001781 | 
| 2969 | GTF2I, BAP135, BTKAP1, DIWS, GTFII-I, IB291, SPIN, TFII-I, WBS, WBSCR6 | general transcription factor IIi | C00001781 | 
| 2971 | GTF3A, AP2, TFIIIA | general transcription factor IIIA | C00001781 | 
| 51512 | GTSE1, B99 | G-2 and S-phase expressed 1 | C00001781 | 
| 2990 | GUSB, BG, MPS7 | glucuronidase, beta (EC:3.2.1.31) | C00001781 | 
| 3033 | HADH, HAD, HADH1, HADHSC, HCDH, HHF4, MSCHAD, SCHAD | hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35) | C00001781 | 
| 3059 | HCLS1, CTTNL, HS1 | hematopoietic cell-specific Lyn substrate 1 | C00001781 | 
| 3006 | HIST1H1C, H1.2, H1C, H1F2, H1s-1 | histone cluster 1, H1c | C00001781 | 
| 3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 | C00001781 | 
| 3148 | HMGB2, HMG2 | high mobility group box 2 | C00001781 | 
| 9324 | HMGN3, PNAS-25, TRIP7 | high mobility group nucleosomal binding domain 3 | C00001781 | 
| 3161 | HMMR, CD168, IHABP, RHAMM | hyaluronan-mediated motility receptor (RHAMM) | C00001781 | 
| 9456 | HOMER1, HOMER, HOMER1A, HOMER1B, HOMER1C, SYN47, Ves-1 | homer homolog 1 (Drosophila) | C00001781 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00001781 | 
| 3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | C00001781 | 
| 3418 | IDH2, D2HGA2, ICD-M, IDH, IDHM, IDP, IDPM, mNADP-IDH | isocitrate dehydrogenase 2 (NADP+), mitochondrial (EC:1.1.1.42) | C00001781 | 
| 10643 | IGF2BP3, CT98, IMP-3, IMP3, KOC1, VICKZ3 | insulin-like growth factor 2 mRNA binding protein 3 | C00001781 | 
| 3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | C00001781 | 
| 3598 | IL13RA2, CD213A2, CT19, IL-13R, IL13BP | interleukin 13 receptor, alpha 2 | C00001781 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00001781 | 
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) | C00001781 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00001781 | 
| 3624 | INHBA, EDF, FRP | inhibin, beta A | C00001781 | 
| 3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | C00001781 | 
| 9270 | ITGB1BP1, ICAP-1A, ICAP-1B, ICAP-1alpha, ICAP1, ICAP1A, ICAP1B | integrin beta 1 binding protein 1 | C00001781 | 
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene | C00001781 | 
| 23189 | KANK1, ANKRD15, CPSQ2, KANK | KN motif and ankyrin repeat domains 1 | C00001781 | 
| 23254 | KAZN, KAZ | kazrin, periplakin interacting protein | C00001781 | 
| 57698 | KIAA1598 | C00001781 | |
| 3832 | KIF11, EG5, HKSP, KNSL1, MCLMR, TRIP5 | kinesin family member 11 | C00001781 | 
| 56992 | KIF15, HKLP2, KNSL7, NY-BR-62 | kinesin family member 15 | C00001781 | 
| 23095 | KIF1B, CMT2, CMT2A, CMT2A1, HMSNII, KLP, NBLST1 | kinesin family member 1B | C00001781 | 
| 10112 | KIF20A, MKLP2, RAB6KIFL | kinesin family member 20A | C00001781 | 
| 9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 | C00001781 | 
| 24137 | KIF4A, KIF4, KIF4G1 | kinesin family member 4A | C00001781 | 
| 3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | C00001781 | 
| 4001 | LMNB1, ADLD, LMN, LMN2, LMNB | lamin B1 | C00001781 | 
| 1902 | LPAR1, EDG2, GPR26, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1 | lysophosphatidic acid receptor 1 | C00001781 | 
| 55227 | LRRC1, LANO, dJ523E19.1 | leucine rich repeat containing 1 | C00001781 | 
| 51690 | LSM7, YNL147W | LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) | C00001781 | 
| 4053 | LTBP2, C14orf141, GLC3D, LTBP3, MSPKA, MSTP031, WMS3 | latent transforming growth factor beta binding protein 2 | C00001781 | 
| 4085 | MAD2L1, HSMAD2, MAD2 | MAD2 mitotic arrest deficient-like 1 (yeast) | C00001781 | 
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) | C00001781 | 
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) | C00001781 | 
| 8550 | MAPKAPK5, MAPKAP-K5, MK-5, MK5, PRAK | mitogen-activated protein kinase-activated protein kinase 5 (EC:2.7.11.1) | C00001781 | 
| 9833 | MELK, HPK38 | maternal embryonic leucine zipper kinase (EC:2.7.11.1 2.7.10.2) | C00001781 | 
| 4311 | MME, CALLA, CD10, NEP, SFE | membrane metallo-endopeptidase (EC:3.4.24.11) | C00001781 | 
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) | C00001781 | 
| 5891 | MOK, RAGE, RAGE-1, RAGE1 | MOK protein kinase (EC:2.7.11.22) | C00001781 | 
| 78988 | MRP63, bMRP63 | mitochondrial ribosomal protein 63 | C00001781 | 
| 51765 | MST4, MASK | serine/threonine protein kinase MST4 (EC:2.7.11.1) | C00001781 | 
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | C00001781 | 
| 26292 | MYCBP, AMY-1 | MYC binding protein | C00001781 | 
| 64151 | NCAPG, CAPG, CHCG, NY-MEL-3 | non-SMC condensin I complex, subunit G | C00001781 | 
| 23397 | NCAPH, BRRN1, CAP-H | non-SMC condensin I complex, subunit H | C00001781 | 
| 10403 | NDC80, HEC, HEC1, HsHec1, KNTC2, TID3, hsNDC80 | NDC80 kinetochore complex component | C00001781 | 
| 4694 | NDUFA1, CI-MWFE, MWFE, ZNF183 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (EC:1.6.99.3) | C00001781 | 
| 51079 | NDUFA13, B16.6, CDA016, GRIM-19, GRIM19 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 | C00001781 | 
| 4696 | NDUFA3, B9, CI-B9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa | C00001781 | 
| 4701 | NDUFA7, B14.5a | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa | C00001781 | 
| 4708 | NDUFB2, AGGG, CI-AGGG | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (EC:1.6.5.3 1.6.99.3) | C00001781 | 
| 4717 | NDUFC1, KFYI | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa | C00001781 | 
| 4718 | NDUFC2, B14.5b, CI-B14.5b, HLC-1, NADHDH2 | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa | C00001781 | 
| 4726 | NDUFS6, CI-13kA, CI-13kD-A, CI13KDA | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) | C00001781 | 
| 4729 | NDUFV2, CI-24k | NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3) | C00001781 | 
| 4776 | NFATC4, NF-ATc4, NFAT3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | C00001781 | 
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | C00001781 | 
| 8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 | C00001781 | 
| 8439 | NSMAF, FAN | neutral sphingomyelinase (N-SMase) activation associated factor | C00001781 | 
| 55270 | NUDT15, MTH2, RP11-90M2.1 | nudix (nucleoside diphosphate linked moiety X)-type motif 15 (EC:3.6.1.55) | C00001781 | 
| 11163 | NUDT4, DIPP2, DIPP2alpha, DIPP2beta | nudix (nucleoside diphosphate linked moiety X)-type motif 4 (EC:3.6.1.52) | C00001781 | 
| 51203 | NUSAP1, ANKT, BM037, LNP, NUSAP, PRO0310p1, Q0310, SAPL | nucleolar and spindle associated protein 1 | C00001781 | 
| 4946 | OAZ1, AZI, OAZ | ornithine decarboxylase antizyme 1 | C00001781 | 
| 11339 | OIP5, 5730547N13Rik, CT86, LINT-25, MIS18B, MIS18beta, hMIS18beta | Opa interacting protein 5 | C00001781 | 
| 401903 | C00001781 | ||
| 126370 | OR1I1, OR19-20, OR1I1P, OR1I1Q | olfactory receptor, family 1, subfamily I, member 1 | C00001781 | 
| 23594 | ORC6, ORC6L | origin recognition complex, subunit 6 | C00001781 | 
| 114884 | OSBPL10, ORP10, OSBP9 | oxysterol binding protein-like 10 | C00001781 | 
| 3355109 | C00001781 | ||
| 5162 | PDHB, PDHBD, PDHE1-B, PHE1B | pyruvate dehydrogenase (lipoamide) beta (EC:1.2.4.1) | C00001781 | 
| 53918 | PELO, PRO1770 | pelota homolog (Drosophila) | C00001781 | 
| 10857 | PGRMC1, HPR6.6, MPR | progesterone receptor membrane component 1 | C00001781 | 
| 8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) | C00001781 | 
| 5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) | C00001781 | 
| 9055 | PRC1, ASE1 | protein regulator of cytokinesis 1 | C00001781 | 
| 5689 | PSMB1, HC5, PMSB1, PSC5 | proteasome (prosome, macropain) subunit, beta type, 1 (EC:3.4.25.1) | C00001781 | 
| 23198 | PSME4, PA200 | proteasome (prosome, macropain) activator subunit 4 | C00001781 | 
| 10728 | PTGES3, P23, TEBP, cPGES | prostaglandin E synthase 3 (cytosolic) (EC:5.3.99.3) | C00001781 | 
| 9232 | PTTG1, EAP1, HPTTG, PTTG, TUTR1 | pituitary tumor-transforming 1 | C00001781 | 
| 5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long | C00001781 | 
| 54870 | QRICH1 | glutamine-rich 1 | C00001781 | 
| 80223 | RAB11FIP1, NOEL1A, RCP, rab11-FIP1 | RAB11 family interacting protein 1 (class I) | C00001781 | 
| 29127 | RACGAP1, CYK4, HsCYK-4, ID-GAP, MgcRacGAP | Rac GTPase activating protein 1 | C00001781 | 
| 5902 | RANBP1, HTF9A | RAN binding protein 1 | C00001781 | 
| 5980 | REV3L, POLZ, REV3 | REV3-like, polymerase (DNA directed), zeta, catalytic subunit (EC:2.7.7.7) | C00001781 | 
| 5985 | RFC5, RFC36 | replication factor C (activator 1) 5, 36.5kDa | C00001781 | 
| 6119 | RPA3, REPA3 | replication protein A3, 14kDa | C00001781 | 
| 393715 | C00001781 | ||
| 6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) | C00001781 | 
| 5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | C00001781 | 
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | C00001781 | 
| 94081 | SFXN1 | sideroflexin 1 | C00001781 | 
| 6502 | SKP2, FBL1, FBXL1, FLB1, p45 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase | C00001781 | 
| 6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 | C00001781 | 
| 79622 | SNRNP25, C16orf33 | small nuclear ribonucleoprotein 25kDa (U11/U12) | C00001781 | 
| 29887 | SNX10, OPTB8 | sorting nexin 10 | C00001781 | 
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) | C00001781 | 
| 6272 | SORT1, Gp95, LDLCQ6, NT3 | sortilin 1 | C00001781 | 
| 6715 | SRD5A1, S5AR_1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (EC:1.3.1.22) | C00001781 | 
| 5552 | SRGN, PPG, PRG, PRG1 | serglycin | C00001781 | 
| 8614 | STC2, STC-2, STCRP | stanniocalcin 2 | C00001781 | 
| 6801 | STRN, SG2NA | striatin, calmodulin binding protein | C00001781 | 
| 8803 | SUCLA2, A-BETA, MTDPS5, SCS-betaA | succinate-CoA ligase, ADP-forming, beta subunit (EC:6.2.1.5) | C00001781 | 
| 8802 | SUCLG1, GALPHA, MTDPS9, SUCLA1 | succinate-CoA ligase, alpha subunit (EC:6.2.1.4 6.2.1.5) | C00001781 | 
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | C00001781 | 
| 85360 | SYDE1, 7h3 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) | C00001781 | 
| 9882 | TBC1D4, AS160 | TBC1 domain family, member 4 | C00001781 | 
| 6996 | TDG, hTDG | thymine-DNA glycosylase (EC:3.2.2.29) | C00001781 | 
| 7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 | C00001781 | 
| 80194 | TMEM134 | transmembrane protein 134 | C00001781 | 
| 28978 | TMEM14A, C6orf73 | transmembrane protein 14A | C00001781 | 
| 80008 | TMEM156 | transmembrane protein 156 | C00001781 | 
| 27346 | TMEM97, MAC30 | transmembrane protein 97 | C00001781 | 
| 7112 | TMPO, CMD1T, LAP2, LEMD4, PRO0868, TP | thymopoietin | C00001781 | 
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | C00001781 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00001781 | 
| 7164 | TPD52L1, D53, hD53 | tumor protein D52-like 1 | C00001781 | 
| 23321 | TRIM2, CMT2R, RNF86 | tripartite motif containing 2 | C00001781 | 
| 57570 | TRMT5, KIAA1393, TRM5 | tRNA methyltransferase 5 (EC:2.1.1.228) | C00001781 | 
| 27075 | TSPAN13, NET-6, NET6, TM4SF13 | tetraspanin 13 | C00001781 | 
| 8458 | TTF2, HuF2 | transcription termination factor, RNA polymerase II | C00001781 | 
| 7272 | TTK, CT96, ESK, MPH1, MPS1, MPS1L1, PYT | TTK protein kinase (EC:2.7.12.1) | C00001781 | 
| 659925 | C00001781 | ||
| 7424 | VEGFC, Flt4-L, VRP | vascular endothelial growth factor C | C00001781 | 
| 80349 | WDR61, REC14, SKI8 | WD repeat domain 61 | C00001781 | 
| 55884 | WSB2, SBA2 | WD repeat and SOCS box containing 2 | C00001781 | 
| 10971 | YWHAQ, 14-3-3, 1C5, HS1 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | C00001781 | 
| 79844 | ZDHHC11, ZNF399 | zinc finger, DHHC-type containing 11 (EC:2.3.1.225) | C00001781 | 
| 678 | ZFP36L2, BRF2, ERF-2, ERF2, RNF162C, TIS11D | ZFP36 ring finger protein-like 2 | C00001781 | 
| 11130 | ZWINT, HZwint-1, KNTC2AP, ZWINT1 | ZW10 interacting kinetochore protein | C00001781 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #202300 | Adrenocortical carcinoma, hereditary; adcc | P04637 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 | P04637 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #605479 | Cholestasis, benign recurrent intrahepatic, 2; bric2 | O95342 | 
| #614972 | Cholestasis, intrahepatic, of pregnancy 3; icp3 | P21439 | 
| #601847 | Cholestasis, progressive familial intrahepatic, 2; pfic2 | O95342 | 
| #602347 | Cholestasis, progressive familial intrahepatic, 3; pfic3 | P21439 | 
| #114500 | Colorectal cancer; crc | P84022 | 
| #614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 | Q13509 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #237500 | Dubin-johnson syndrome; djs | Q92887 | 
| #128101 | Dystonia 4, torsion, autosomal dominant; dyt4 | P04350 | 
| #133239 | Esophageal cancer | P04637 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a | Q13509 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #600803 | Gallbladder disease 1; gbd1 | P21439 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #237450 | Hyperbilirubinemia, rotor type; hblrr | Q9NPD5 Q9Y6L6 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #612438 | Leukodystrophy, hypomyelinating, 6; hld6 | P04350 | 
| #151623 | Li-fraumeni syndrome 1; lfs1 | P04637 | 
| #611603 | Lissencephaly 3; lis3 | Q71U36 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 P04637 | 
| #613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related | Q9H4B7 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #607948 | Mycobacterium tuberculosis, susceptibility to | P11473 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260500 | Papilloma of choroid plexus; cpp | P04637 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #172700 | Pick disease of brain | P10636 | 
| #610031 | Polymicrogyria, symmetric or asymmetric; pmgysa | Q9BVA1 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #275355 | Squamous cell carcinoma, head and neck; hnscc | P04637 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #187950 | Thrombocythemia 1; thcyt1 | P40225 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a | P11473 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) P04637 (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H00624 | Familial cholestasis | O95342
                            (related) P21439 (related) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P04637 (related) P04637 (marker) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) P04637 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) P04637 (related) Q92731 (marker) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00005 | Chronic lymphocytic leukemia (CLL) | P04183
                            (marker) P04637 (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) P04637 (related) P04637 (marker) | 
| H00027 | Ovarian cancer | P04626
                            (related) P04637 (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) P04637 (related) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P04637 (related) P35354 (related) | 
| H00004 | Chronic myeloid leukemia (CML) | P04637
                            (related) | 
| H00006 | Hairy-cell leukemia | P04637
                            (related) | 
| H00008 | Burkitt lymphoma | P04637
                            (related) | 
| H00009 | Adult T-cell leukemia | P04637
                            (related) | 
| H00010 | Multiple myeloma | P04637
                            (related) | 
| H00013 | Small cell lung cancer | P04637
                            (related) | 
| H00014 | Non-small cell lung cancer | P04637
                            (related) | 
| H00015 | Malignant pleural mesothelioma | P04637
                            (related) | 
| H00020 | Colorectal cancer | P04637
                            (related) P04637 (marker) | 
| H00025 | Penile cancer | P04637
                            (related) P04637 (marker) P14780 (related) P35354 (related) | 
| H00029 | Vulvar cancer | P04637
                            (related) | 
| H00032 | Thyroid cancer | P04637
                            (related) | 
| H00036 | Osteosarcoma | P04637
                            (related) P08684 (marker) | 
| H00038 | Malignant melanoma | P04637
                            (related) | 
| H00039 | Basal cell carcinoma | P04637
                            (related) | 
| H00040 | Squamous cell carcinoma | P04637
                            (related) | 
| H00041 | Kaposi's sarcoma | P04637
                            (related) | 
| H00044 | Cancer of the anal canal | P04637
                            (related) | 
| H00047 | Gallbladder cancer | P04637
                            (related) | 
| H00048 | Hepatocellular carcinoma | P04637
                            (related) | 
| H00881 | Li-Fraumeni syndrome | P04637
                            (related) | 
| H01007 | Choroid plexus papilloma | P04637
                            (related) | 
| H00021 | Renal cell carcinoma | P04637
                            (marker) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00342 | Tuberculosis | P11473
                            (related) | 
| H00784 | Localized autosomal recessive hypotrichosis | P11473
                            (related) | 
| H01143 | Vitamin D-dependent rickets | P11473
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H01213 | Gallbladder disease | P21439
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) | P40225
                            (marker) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q03164
                            (related) Q03164 (marker) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) | Q13509
                            (related) | 
| H00268 | Lissencephaly (LIS) | Q71U36
                            (related) | 
| H00208 | Hyperbilirubinemia | Q92887
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D015746 | Abdominal Pain | C00001781 | 
| C538231 | Adenocarcinoma of lung | C00001781 | 
| D000380 | Agranulocytosis | C00001781 | 
| D000505 | Alopecia | C00001781 | 
| D000787 | Angina Pectoris | C00001781 | 
| D018771 | Arthralgia | C00001781 | 
| D001342 | Autonomic Nervous System Diseases | C00001781 | 
| D019575 | Blindness, Cortical | C00001781 | 
| C536572 | Bone Marrow failure syndromes | C00001781 | 
| D001919 | Bradycardia | C00001781 | 
| D001943 | Breast Neoplasms | C00001781 | 
| D006502 | Budd-Chiari Syndrome | C00001781 | 
| D002277 | Carcinoma | C00001781 | 
| D018236 | Carcinoma, Embryonal | C00001781 | 
| D002289 | Carcinoma, Non-Small-Cell Lung | C00001781 | 
| D002292 | Carcinoma, Renal Cell | C00001781 | 
| D002295 | Carcinoma, Transitional Cell | C00001781 | 
| D002637 | Chest Pain | C00001781 | 
| D023341 | Chills | C00001781 | 
| D015179 | Colorectal Neoplasms | C00001781 | 
| D003248 | Constipation | C00001781 | 
| D003324 | Coronary Artery Disease | C00001781 | 
| D003967 | Diarrhea | C00001781 | 
| D004342 | Drug Hypersensitivity | C00001781 | 
| D062787 | Drug Overdose | C00001781 | 
| D064420 | Drug-Related Side Effects and Adverse Reactions | C00001781 | 
| D004407 | Dysgerminoma | C00001781 | 
| D007172 | Erectile Dysfunction | C00001781 | 
| D005157 | Facial Pain | C00001781 | 
| D005334 | Fever | C00001781 | 
| D005734 | Gangrene | C00001781 | 
| D006258 | Head and Neck Neoplasms | C00001781 | 
| D006314 | Hearing Loss, Conductive | C00001781 | 
| D006333 | Heart Failure | C00001781 | 
| D006463 | Hemolytic-Uremic Syndrome | C00001781 | 
| D006504 | Hepatic Veno-Occlusive Disease | C00001781 | 
| D006505 | Hepatitis | C00001781 | 
| D006646 | Histiocytosis, Langerhans-Cell | C00001781 | 
| D006689 | Hodgkin Disease | C00001781 | 
| D006932 | Hyperbilirubinemia | C00001781 | 
| D006973 | Hypertension | C00001781 | 
| D006978 | Hypertension, Renovascular | C00001781 | 
| D006987 | Hypesthesia | C00001781 | 
| D007008 | Hypokalemia | C00001781 | 
| D007010 | Hyponatremia | C00001781 | 
| D007022 | Hypotension | C00001781 | 
| D045823 | Ileus | C00001781 | 
| D007177 | Inappropriate ADH Syndrome | C00001781 | 
| D007511 | Ischemia | C00001781 | 
| D007674 | Kidney Diseases | C00001781 | 
| D007970 | Leukopenia | C00001781 | 
| D008113 | Liver Neoplasms | C00001781 | 
| D008545 | Melanoma | C00001781 | 
| D008881 | Migraine Disorders | C00001781 | 
| D009120 | Muscle Cramp | C00001781 | 
| D018908 | Muscle Weakness | C00001781 | 
| D009135 | Muscular Diseases | C00001781 | 
| D009188 | Myelitis, Transverse | C00001781 | 
| D009203 | Myocardial Infarction | C00001781 | 
| D017202 | Myocardial Ischemia | C00001781 | 
| D009325 | Nausea | C00001781 | 
| D009362 | Neoplasm Metastasis | C00001781 | 
| D009374 | Neoplasms, Experimental | C00001781 | 
| D009373 | Neoplasms, Germ Cell and Embryonal | C00001781 | 
| D009443 | Neuritis | C00001781 | 
| D020258 | Neurotoxicity Syndromes | C00001781 | 
| D009503 | Neutropenia | C00001781 | 
| D010051 | Ovarian Neoplasms | C00001781 | 
| D010146 | Pain | C00001781 | 
| D010291 | Paresis | C00001781 | 
| D010292 | Paresthesia | C00001781 | 
| D016506 | Pemphigus, Benign Familial | C00001781 | 
| D010523 | Peripheral Nervous System Diseases | C00001781 | 
| D010538 | Peritonitis | C00001781 | 
| D011014 | Pneumonia | C00001781 | 
| D054038 | Posterior Leukoencephalopathy Syndrome | C00001781 | 
| D011471 | Prostatic Neoplasms | C00001781 | 
| D011507 | Proteinuria | C00001781 | 
| D011552 | Pseudomonas Infections | C00001781 | 
| D011658 | Pulmonary Fibrosis | C00001781 | 
| D011928 | Raynaud Disease | C00001781 | 
| D012021 | Reflex, Abnormal | C00001781 | 
| D012078 | Renal Artery Obstruction | C00001781 | 
| D051437 | Renal Insufficiency | C00001781 | 
| D012208 | Rhabdomyosarcoma | C00001781 | 
| D012514 | Sarcoma, Kaposi | C00001781 | 
| D012640 | Seizures | C00001781 | 
| D018805 | Sepsis | C00001781 | 
| D018243 | Teratocarcinoma | C00001781 | 
| D013736 | Testicular Neoplasms | C00001781 | 
| D013921 | Thrombocytopenia | C00001781 | 
| D013927 | Thrombosis | C00001781 | 
| D014523 | Urethral Neoplasms | C00001781 | 
| D001749 | Urinary Bladder Neoplasms | C00001781 | 
| D014625 | Vaginal Neoplasms | C00001781 | 
| D014652 | Vascular Diseases | C00001781 | 
| D014839 | Vomiting | C00001781 |